Disclosure of interest: nothing to discloser E-Posters - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.01 - ACUTE MANAGEMENT - Neither thrombolysis nor thrombectomy P2109 - ESOC25-1903 TRIIODOTHYRONINE TREATMENT REDUCES STROKE VOLUME AND IMPROVES NEUROLOGICAL FUNCTION IN A MOUSE MODEL OF ISCHEMIC STROKE Daniel Ullrich 1,2 , Heike Heuer 2,3 , Steffen Mayerl 2,3 , Dagmar Fhrer 2,3 , Christoph Kleinschnitz 1,2 , Friederike Langhauser 1,2 1 Department of Neurology, University Hospital Essen, Germany, Essen, Germany, 2 Center for Translational Neuro- and Behavioural Sciences (C-TNBS), University Hospital Essen, Germany, E, Germany, 3 Department of Endocrinology, Diabetes and Metabolism, University Hospital Essen, University Duisburg-Essen, Germany, Essen, Germany Background and Aims: Thyroid hormones affect the central nervous system's response to various stimuli such as ischemic stroke
However, if you notice any changes in your cycle or increased cramping, consider reducing the dose or consulting a healthcare provider
Plasma biochemistry Non-fasted terminal blood was sampled from the tail vein, kept on ice and centrifuged (5 min, 4 C, 6000 g ) to generate EDTA-stabilized plasma
The company was said to have considered an offering in 2016, but stayed private as it retooled and in 2018 took $200 million from consumer private equity giant L Catterton
Lee Y, Kang H, Lee B, Zhang Y, Kim Y, Kim S, et al
